Outcome of immune checkpoint inhibitors in patients with extensive-stage small-cell lung cancer and brain metastases

OBJECTIVES: Brain metastases (BMs) are common in extensive-stage small-cell lung cancer (SCLC) and are underrepresented in pivotal clinical trials that demonstrate the efficacy of immune checkpoint inhibitors (ICIs). We conducted a retrospective analysis to assess the role of ICIs in BM lesions in l...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chunyu, Mu, Shuai, Yang, Xuhui, Li, Lingling, Tao, Haitao, Zhang, Fan, Li, Ruixin, Hu, Yi, Wang, Lijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196483/
https://www.ncbi.nlm.nih.gov/pubmed/37213269
http://dx.doi.org/10.3389/fonc.2023.1110949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196483/
https://www.ncbi.nlm.nih.gov/pubmed/37213269
http://dx.doi.org/10.3389/fonc.2023.1110949

Ejemplares similares